From Scan to Treatment Plan, AI Helps Close Breast Cancer’s Deadliest Gaps
NVIDIA · 5 Oct 2026, 23:00 AEST
Breast cancer remains the most commonly diagnosed cancer among American women, with significant gaps in care. AI applications are being developed to enhance imaging, risk assessment, and treatment planning, addressing these critical issues.
Key facts
- A majority of women over age 40 skip the recommended annual screening.
- Companies in the NVIDIA Inception program for startups are building AI applications to support clinicians at each of these friction points, including imaging, risk assessment and treatment planning.
- iSono Health's FDA-cleared ATUSA platform captures a standardized breast volume in approximately two minutes per breast, compared with up to 45 minutes for a conventional handheld ultrasound.
- Ataraxis AI is building clinical intelligence that predicts patient outcomes and response to different therapies using digital data, including pathology slides that are already part of the standard patient workup.
Read aloud
Breast cancer remains the most commonly diagnosed cancer among American women, with significant gaps in care. A I applications are being developed to enhance imaging, risk assessment, and treatment planning, addressing these critical issues. A majority of women over age forty skip the recommended annual screening. Companies in the NVIDIA Inception program for startups are building A I applications to support clinicians at each of these friction points, including imaging, risk assessment and treatment planning. iSono Health's FDA-cleared ATUSA platform captures a standardized breast volume in approximately two minutes per breast, compared with up to forty five minutes for a conventional handheld ultrasound. Ataraxis A I is building clinical intelligence that predicts patient outcomes and response to different therapies using digital data, including pathology slides that are already part of the standard patient workup.
Sources in this cluster
- From Scan to Treatment Plan, AI Helps Close Breast Cancer’s Deadliest Gaps
NVIDIA · 5 Oct 2026, 23:00 AEST